|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.18 CNY | -1.09% |
|
-0.98% | -13.32% |
| May. 20 | Wall Street Cues, Central Bank Outlooks Lift Asian Stock Markets | MT |
| Apr. 29 | Liaoning Chengda Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Liaoning Chengda Biotechnology Co.,Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 364.71 million compared to CNY 353.52 million a year ago. Net income was CNY 81.46 million compared to CNY 127.04 million a year ago.
Basic earnings per share from continuing operations was CNY 0.2 compared to CNY 0.31 a year ago. Diluted earnings per share from continuing operations was CNY 0.2 compared to CNY 0.31 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -13.32% | 1.63B | |
| -3.15% | 89.69B | |
| +2.50% | 41.34B | |
| -12.32% | 33.72B | |
| +62.74% | 26.11B | |
| -20.75% | 14.63B | |
| -8.97% | 12.84B | |
| -12.34% | 11.66B | |
| -43.92% | 11.52B | |
| +4.27% | 8.92B |
LIAONING CHENGDA BIOTECHNOLOGY CO.,LTD. 
